Abstract
The perinate is particularly risk-prone to chemical species which have the potential of inducing neuronal apoptosis or necrosis and thereby adversely altering development of the brain, to produce life-long functional and behavioral deficits. This paper is an overview for many substances of abuse, but the purview is much more broadened by the realization that even elevated levels of estrogens and corticosteroids in the pregnant mother can act as neuroteratogens, by passing via the placenta and altering neural development or inducing apoptosis in the perinate. Finally, therapeutic risks of anesthetics are highlighted, as these too induce neuronal apoptosis in the neonate by either blocking N-methyl-D-aspartate receptors or by acting as gamma-aminobutyric acid agonists. By understanding the mechanisms involved it may ultimately be possible to interrupt the mechanistic scheme and thereby prevent neuroteratological processes.
Similar content being viewed by others
References
Archer, T. and Fredriksson, A. (1992) “Functional changes implicating dopaminergic systems following perinatal treatments”, Dev. Pharmacol. Ther. 18, 201–222.
Archer, T., Danysz, W., Fredriksson, A., Jonsson, G., Luthman, J., Sundström, E. and Teiling, A. (1988) “Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning”, Pharmacol. Biochem. Behav. 31, 357–364.
Archer, T., Beninger, R.J., Järbe, T.U.C. and Seiden, L.S. (1990) “Latent learning in a radial arm maze following neonatal dopamine depletion”, Behav. Pharmacol. 1, 191–199.
Archer, T., Palomo, T. and Fredriksson, A. (2002) “Neonatal 6-hydroxydopamine-induced hypo/hyperactivity: blockade by dopamine reuptake inhibitors and effect of acute d-amphetamine”, Neurotoxicity Res. 4, 247–266.
Azcoitia, I., Doncarlos, L.L. and Garcia-Segura, L.M. (2002) “Estrogen and brain vulnerability”, Neurotoxicity Res. 4, 235–245.
Barbazanges, A., Piazza, P.V., Le Moal, M. and Maccari, S. (1996) “Maternal glucocorticoid secretion mediates long-term effects of prenatal stress”, J. Neurosci. 16, 3943–3949.
Barden, N., Reul, J.M. and Holsboer, F. (1995) “Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?”, Trends Neurosci. 18, 6–11.
Barr, H.M. and Streissguth, A.P. (2001) “Identifying maternal self-reported alcohol use associated with fetal alcohol spectrum disorders”, Alcohol. Clin. Exp. Res. 25, 283–287.
Behl, C. and Holsboer, F. (1999) “The female sex hormone oestrogen as a neuroprotectant”, Trends Pharmacol. Sci. 20, 441–444.
Bespalov, A.Y., Balster, R.L. and Beardsley, P.M. (1999) “N-methyl-d-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats”, J. Pharmacol. Exp. Ther. 290, 20–27.
Blue, M.E., Erzurumlu, R.S. and Jhaveri, S. (1991) “A comparison of pattern formation by the thalamocortical and serotonergic afferents in the rat barrel field cortex”, Cereb. Cortex 1, 380–389.
Bonnin, A., de Miguel, R., Castro, J.G., Ramos, J.A. and Fernández-Ruiz, J.J. (1996) “Effects of perinatal exposure to Δ9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase containing neurons in rat brain”, J. Mol. Neurosci. 7, 291–308.
Brodie, M.S. and Appel, S.B. (2000) “Dopaminergic neurons in the ventral tegmental area of C57BL/6J and DBA/2J mice differ in sensitivity to ethanol excitation”, Alcohol. Clin. Exp. Res. 24, 1120–1124.
Carboni, E., Bortone, L., Giua, C. and DiChiara, G. (2000) “Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats”, Drug Alcohol Depend. 58, 93–102.
Cartwright, M.M., Tessmer, L.L. and Smith, S.M. (1998) “Ethanol-induced neural crest apoptosis is coincident with their endogenous death, but is mechanistically distinct”, Alcohol. Clin. Exp. Res. 22, 142–149.
Cesarec, Z. and Nyman, A.K. (1985) “Differential response to amphetamine in schizophrenia”, Acta Psychiatr. Scand. 71, 523–538.
Chen, S.Y. and Sulik, K.K. (1996) “Free radicals and ethanol-induced cytotoxicity in neural crest cells”, Alcohol. Clin. Exp. Res. 20, 1071–1076.
Chowen, J.A., Torres-Aleman, I. and Garcia-Segura, L.M. (1992) “Trophic effects of estradiol on fetal rat hypothalamic neurons”, Neuroendocrinology 56, 895–901.
Coccaro, E.F. and Murphy, D.L. (1990) Serotonin in major psychiatric disorders (American Psych. Press, Washington, DC).
Cooper, R.L., Goldenberg, R.L., Das, A., Elder, N., Swain, M., Norman, G., Ramsey, R., Cotroneo, P., Collins, B.A., Johnson, F., Jones, P. and Meier, A.M. (1996) “The preterm prediction study: maternal stress is associated with spontaneous preterm brith at less than thirty-five weeks' gestation. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network”, Am. J. Obstet. Gynecol. 175, 1286–1292.
Corchero, J., García-Gil, L., Manzanares, J., Fernández-Ruiz, J.J., Fuentes, J.A. and Ramos, J.A. (1998) “Perinatal Δ9-tetrahydrocannabinol exposure reduces proenkephalin gene expresion in the caudate-putamen of adult female rats”, Life Sci. 63, 843–850.
Dalterio, S.L. (1986) “Cannabinoid exposure: effects on development”, Neurobehav. Toxicol. Teratol. 8, 345–352.
Dalterio, S.L. and Barke, A. (1979) “Perinatal exposure to cannabinoids alter male reproductive functions in mice”, Science 205, 1420–1422.
Del Arco, I., Muñoz, R., Rodríguez, F., Escudero, L., Martin, J.L., Navarro, M. and Villanúa, M.A. (2000) “Maternal exposure to the synthetic cannabinoid HU-210: effects on the endocrine and immune systems of the adult male offspring”, Neuroimmunomodulation 7, 16–26.
Deminiere, J.M., Piazza, P.V., Guegan, G., Abrous, N., Maccari, S., Le Moal, M. and Simon, H. (1992) “Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers”, Brain Res. 586, 135–139.
Dessens, A.B., Cohen-Kettenis, P.T., Mellenbergh, G.J., Koppe, J.G., van de Poll, N.E. and Boer, K. (2000) “Association of prenatal phenobarbital and phenytoin exposure with small head size and with learning problems”, Acta Paediatr. 89, 533–541.
Diaz-Granados, J.L., Spuhler-Phillips, K., Lilliquist, M.W., Amsel, A. and Leslie, S.W. (1997) “Effects of prenatal and early postnatal ethanol exposure on (3H).MK-801 binding in rat cortex and hippocampus”, Alcohol. Clin. Exp. Res. 21, 874–881.
Dikranian, K., Ishimaru, M.J., Tenkova, T., Labruyere, J., Qin, Y.Q., Ikonomidou, C. and Olney, J.W. (2001a) “Apoptosis in the in vivo mammalian forebrain”, Neurobiol. Dis. 8, 359–379.
Dikranian, K., Tenkova, T., Bittigau, P., Ikonomidou, C. and Olney, J.W. (2001b) “Histological characterization of apoptotic neurodegeneration induced in the developing rat brain by drugs that block sodium channels”, Soc. Neurosci. Abstr. 26, 323.
Diwan, A., Castine, M., Pomerleau, C.S., Meador-Woodruff, J.H. and Dalack, G.W. (1998) “Differential prevalence of cigarette smoking in patients with schizophrenic vs. mood disorders”, Schizophr. Res. 33, 113–118.
Dodel, R.C., Du, Y., Bales, K.R., Gao, F. and Paul, S.M. (1999) “Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappaB trnaslocation in cultured rat astroglial cultures following exposure to amyloid A beta(1–40) and lipopolysaccharides”, J. Neurochem. 73, 1453–1460.
Druse, M.J., Kuo, A. and Tajuddin, N. (1991) “Effects of in utero ethanol exposure on the developing serotonergic system”, Alcohol. Clin. Exp. Res. 15, 678–684.
Dueñas, M., Torres-Aleman, I., Naftolin, F. and Garcia-Segura, L.M. (1996) “Interaction of insulin-like growth factor-1 and estradiol signaling pathways on hypothalamic neuronal differentiation”, Neuroscience 74, 531–539.
Duester, G., Deltour, L. and Ang, H.L. (1996) “Evidence that class IV alcohol dehydrogenase may function in embryonic retinoic acid synthesis”, In: Weiner, H., ed, Enzymology and Molecular Biology of Carbonyl Metabolism (Plenum Press, New York, NY), pp 357–364.
Edwards, G. (1990) “Withdrawal symptoms and alcohol dependence: fruitful mysteries”, Br. J. Addict. 85, 447–461.
Famy, C., Streissguth, A.P. and Unis, A.S. (1998) “Mental illness in adults with fetal alcohol syndrome or fetal alcohol effects”, Am. J. Psychiatry 155, 552–554.
Fils-Aime, M.L., Eckardt, M.J., George, D.T., Brown, G.L., Mefford, I. and Linnoila, M. (1996) “Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than lateonset alcoholics”, Arch. Gen. Psychiatry 53, 211–216.
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M.C., Reimherr, F., Wender, P., Yaw, J., Young, D.A., Breese, C.R., Adams, C., Patterson, D., Adler, L.E., Kruglyak, L., Leonard, S. and Byerley, W. (1997) “Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus”, Proc. Natl Acad. Sci. USA 94, 587–592.
Fride, E. and Mechoulam, R. (1996a) “Developmental aspects of anandamide: ontogeny of response and prenatal exposure”, Psychoneuroendocrinology 21, 157–172.
Fride, E. and Mechoulam, R. (1996b) “Ontogenic development of the response to anandamide and Δ9-tetrahydrocannabinol in mice”, Dev. Brain Res. 95, 131–134.
García-Gil, L., de Miguel, R., Ramos, J.A. and Fernández-Ruiz, J.J. (1996) “Perinatal Δ9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs”, Drug Alcohol Depend. 42, 155–166.
García-Gil, L., Ramos, J.A., Rubino, T., Parolaro, D. and Fernández-Ruiz, J.J. (1998) “Perinatal Δ9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats”, Neurotoxicol. Teratol. 20, 549–553.
García-Gil, L., de Miguel, R., Romero, J., Pérez, A., Ramos, J.A. and Fernández-Ruiz, J.J. (1999) “Perinatal Δ9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA-B but not GABA-A, receptor agonists in adult rats”, Neurotoxicol. Teratol. 21, 277–283.
Garcia-Segura, L.M., Naftolin, F., Hutchison, J.B., Azcoitia, I. and Chowen, J.A. (1999a) “Role of astroglia in estrogen regulation of synaptic plasticity and brain repair”, J. Neurobiol. 40, 574–584.
Garcia-Segura, L.M., Wozniack, A., Azcoitia, I., Rodriguez, J.R., Hutchison, R.E. and Hutchison, J.B. (1999b) “Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair”, Neuroscience 89, 567–578.
Garcia-Segura, L.M., Cardona-Gomez, G.P., Chowen, J.A. and Azcoitia, I. (2000) “Insulin-like growth factor-I receptors and estrogen receptors interact in the promotion of neuronal survival and neuroprotection”, J. Neurocytol. 29, 425–437.
Garcia-Segura, L.M., Azcoitia, I. and DonCarlos, L.L. (2001) “Neuroprotection by estradiol”, Prog. Neurobiol. 63, 29–60.
Gawin, F.H. and Kleber, H.D. (1986) “Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations”, Arch. Gen. Psychiatry 43, 107–113.
George, T.P., Sernyak, M.J., Ziedonis, D.M. and Woods, S.W. (1995) “Effects of clozapine on smoking in chronic schizophrenic outpatients”, J. Clin. Psychiatry 56, 344–346.
Geyer, M.A. and Braff, D.L. (1987) “Startle habituation and sensorimotor gating in schizophrenia and related animal models”, Schizophr. Bull. 13, 643–668.
Glover, V. (1997) “Maternal stress or anxiety in pregnancy and emotional development of the child”, Br. J. Psychiatry 171, 105–106.
Gollapudi, L. and Oblinger, M.M. (1999a) “Stable transfection of PC12 cells with estrogen receptor (ERα).: protective effects of estrogen on cell survival after serum deprivation”, J. Neurosci. Res. 56, 99–108.
Gollapudi, L. and Oblinger, M.M. (1999b) “Estrogen and NGF synergistically protect terminally differentiated ERα-transfected PC12 cells from apoptosis”, J. Neurosci. Res. 56, 471–481.
Gongwer, M.A., Murphy, J.M., McBride, W.J., Lumeng, L. and Li, T.K. (1989) “Regional brain contents of serotonin, dopamine and their metabolites in the selectively bred high- and low-alcohol drinking lines of rats”, Alcohol Alcohol. 6, 317–320.
Gressens, P., Lammens, M., Picard, J.J. and Evrard, P. (1992) “Ethanol-induced disturbances of gliogenesis and neurogenesis in the developing murine brain: an in vitro and in vivo immunohistochemical and ultrastructural study”, Alcohol Alcohol. 27, 219–226.
Guerri, C. (2002) “Mechanisms involved in central nervous system dysfunctions induced by prenatal ethanol exposure”, Neurotoxicity Res. 4, 327–335.
Guerri, C. and Renau-Piqueras, J. (1997) “Alcohol, astroglia, and brain development”, Mol. Neurobiol. 15, 65–81.
Guerri, C., Climent, E. and Pascual, M. (2001) “Ethanol exposure enhances apoptosis during brain development and affects brain-derived neurotrophic factor and its TrkB receptors”, Alcohol Alcohol. 36, 437.
Haertzen, C.A. and Hooks, Jr, N.T. (1969) “Changes in personality as subjective experience associated with the chronic administration and withdrawal of opiates”, J. Nerv. Ment. Dis. 148, 606–614.
Halliday, G., Ellis, J., Heard, R., Caine, D. and Harper, C. (1993) “Brainstem serotonergic neurons in chronic alcoholics with and without the memory impairment of Korsakoff's psychosis”, J. Neuropathol. Exp. Neurol. 52, 567–579.
Halliday, G., Baker, K. and Harper, C. (1995) “Serotonin and alcohol-related brain damage”, Metab. Brain Dis. 10, 25–30.
Harrison, A.A., Liem, Y.T. and Markou, A. (2001) “Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats”, Neuropsychopharmacology 25, 55–71.
Hartman, R.E., Jevtovic-Todorovic, V., Olney, J.W. and Wozniak, D.F. (2001) “Neonatal exposure to common anesthetics leads to spatial learning deficits in juvenile rats”, Soc. Neurosci. Abstr. 27, 772.5.
Henningfield, J.E., Johnson, R.E. and Jasinski, D.R. (1987) “Clinical procedures for the assessment of abuse potential”, In: Bozarth, M.A., ed, Methods of Assessing the Reinforcing Properties of Abused Drugs (Springer-Verlag, New York), pp 573–590.
Henry, C., Guegant, G., Cador, M., Arnauld, E., Arsaut, J., Le Moal, M. and Demotes-Mainard, J. (1995) “Prenatal stress in rats facilitates amphetamine-induced sensitization and induces long-lasting changes in dopamine receptors in the nucleus accumbens”, Brain Res. 685, 179–186.
Hurt, R.D., Sachs, D.P.L., Glover, E.D., Offord, K.P., Johnston, J.A., Dale, L.C., Khayrallah, M.A., Schroeder, D.R., Glover, P.N., Sullivan, C.R., Croghan, I.T. and Sullivan, P.M. (1997) “A comparison of sustained-release buproprion and placebo for smoking cessation”, N. Engl. J. Med. 337, 1195–1202.
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vockler, J., Dikranian, K., Tenkova, T., Stevoska, V., Turski, L. and Olney, J.W. (1999) “Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain”, Science 283, 70–74.
Ikonomidou, C., Bittigau, P., Ishimaru, M.J., Wozniak, D.F., Koch, C., Genz, K., Price, M.T., Stefovska, V., Horster, F., Tenkova, T., Dikranian, K. and Olney, J.W. (2000a) “Drug-induced damage in the developing brain”, Science 288, 976–977.
Ikonomidou, C., Bittigau, P., Ishimaru, M.J., Wozniak, D.F., Koch, C., Genz, K., Price, M.T., Stefovska, V., Horster, F., Tenkova, T., Dikranian, K. and Olney, J.W. (2000b) “Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome”, Science 287, 1056–1060.
Ikonomidou, C., Genz, K., Engelbrechten, S., Dikranian, K., Olney, J.W. and Bittigau, P. (2000c) “Antiepileptic drugs which block sodium channels cause neuronal apoptosis in the developing rat brain”, Soc. Neurosci. Abstr. 26, 323.
Ikonomidou, C., Bittigau, P., Koch, C., Genz, K., Hoerster, F., Felderhoff-Mueser, U., Tenkova, T., Dikranian, K. and Olney, J.W. (2001) “Neurotransmitters and apoptosis in the developing brain”, Biochem. Pharmacol. 62, 401–405.
Insel, T.R. (1995) “The development of brain and behavior”, In: Bloom, F.E. and Kupfer, D.J. eds, Psychopharmacology: The Four Generation of Progress (Raven Press, New York), pp 683–694.
Jaffe, J.H. (1990) “Drug addiction and drug abuse”, In: Rall, T.W., Nies, A.S. and Taylor, P., eds, Goodman & Gilman's Pharmacological Basis of Therapeutics, 8th edition (Pergamon Press, Elmsford, NY), pp 522–573.
Javors, M., Tiouririne, M. and Prihoda, T. (2000) “Platelet serotonin uptake is higher in early-onset than in late-onset alcoholics”, Alcohol Alcohol. 35, 390–393.
Jevtovic-Todorovic, V., Wozniak, D.F., Benshoff, N. and Olney, J.W. (2001) “Commonly used anesthesia protocol causes neuronal suicide in the immature rat brain”, Soc. Neurosci. Abstr. 27, 772.4.
Jeziorski, M., White, F.J. and Wolf, M.E. (1994) “MK-801 prevents the development of behavioral sensitization during repeated morphine administration”, Synapse 16, 137–147.
Jones, K.L. and Smith, D.W. (1975) “The fetal alcohol syndrome”, Teratology 12, 1–10.
Jones, K.L., Smith, D.W., Ulleland, C.N. and Streissguth, A.P. (1973) “Pattern of malformation in offspring of chronic alcoholic mothers”, Lancet I, 1267–1271.
Jorenby, D.E., Leischow, S.J., Nides, M.A., Rennard, S.I., Johnston, J.A., Hughes, A.R., Smith, S.S., Muramoto, M.L., Daughton, D.M., Doan, K., Fiore, M.C. and Baker, T.B. (1999) “A controlled trial of sustained-release buproprion, a nicotine patch, or both for smoking cessation”, N. Engl. J. Med. 340, 685–691.
Katner, S.N. and Weiss, F. (2001) “Neurochemical characteristics associated with ethanol preference in selected alcohol-preferring and_-nonpreferring rats: a quantitative microdialysis study”, Alcohol. Clin. Exp. Res. 25, 198–205.
Khantzian, E.J. (1985) “The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence”, Am. J. Psychiatry 142, 1259–1264.
Khantzian, E.J. (1997) “The self-medication hypothesis of substance use disorders: a reconsideration and recent applications”, Harvard Rev. Psychiatry 4, 231–244.
Koehl, M., Barbazanges, A., Le Moal, M. and Maccari, S. (1997) “Prenatal stress induces a phase advance of circadian corticosterone rhythm in adult rats which is prevented by postnatal stress”, Brain Res. 759, 317–320.
Koehl, M., Darnaudery, M., Dulluc, J., Van Reeth, O., Le Moal, M. and Maccari, S. (1999) “Prenatal stress alters circadian activity of hypothalamo-pituitary- adrenal axis and hippocampal corticosteroid receptors in adult rats of both gender”, J. Neurobiol. 40, 302–315.
Koehl, M., Bjijou, Y., Le Moal, M. and Cador, M. (2000) “Nicotine-induced locomotor activity is increased by preexposure of rats to prenatal stress”, Brain Res. 882, 196–200.
Koehl, M., Lemaire, V., Mayo., W., Abrous, D.N., Maccari, S., Piazza, P.V., Le Moal, M. and Vallee, M. (2002) “Individual vulnerability to substance abuse and affective disorders: role of early environmental influences”, Neurotoxicity Res. 4, 281–296.
Kotch, L.A. and Sulik, K.K. (1992) “Experimental fetal alcohol syndrome: proposed pathogenic basis for a variety of associated facial and brain anomalies”, Am. J. Med. Genet. 44, 168–176.
Krystal, J.H., D'Souza, D.C., Madonick, S. and Petrakis, I.L. (1999) “Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients”, Schizophr. Res. 35, S35-S49.
Lauder, J.M. (1990) “Ontogeny of the serotonergic, system in the rat: serotonin as a developmental signal”, Ann. N.Y. Acad. Sci. 600, 297–313.
Lieber, C.S. (1988) “Biochemical and molecular basis of alcohol-induced injury to liver and other tissues”, N. Engl. J. Med. 319, 1639–1650.
Luo, J. and Miller, M.W. (1999) “Platelet-derived growth factor-mediated signal transduction underlying astrocyte proliferation: site of ethanol action”, J. Neurosci. 19, 10014–10025.
Luthman, J., Fredriksson, A., Lewander, T., Jonsson., G. and Archer, T. (1989) “Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment”, Psychopharmacology 99, 550–557.
Luthman, J., Fredriksson, A., Plaznik A. and Archer, T. (1991) “Ketanserin or mianserin treatment reverses, hyperactivity in neonatally dopamine lesioned rats”, J. Psychopharmacol. 5, 418–425.
Luthman, J., Bassen, M., Fredriksson, A. and Archer, T. (1997) “Functional changes induced by neonatal 6-hydroxydopamine lesions: effects of dose levels on behavioural parameters”, Behav. Brain Res. 82, 213–221.
Maccari, S., Piazza, P.V., Kabbaj, M., Barbazanges, A., Simon, H. and Le Moal, M. (1995) “Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress”, J. Neurosci. 15, 110–116.
Maier, S.E., Chen, W.J. and West, J.R. (1996) “Prenatal binge-like alcohol exposure alters neurochemical profiles in fetal rat brain”, Pharmacol. Biochem. Behav. 55, 521–529.
Mailleux, P. and Vanderhaeghen, J.J. (1992a) “Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons”, Neurosci. Lett. 148, 173–176.
Mailleux, P. and Vanderhaeghen, J.J. (1992b) “Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridation histochemistry”, Neuroscience 48, 655–668.
Mallet, P.E. and Beninger, R.J. (1996) “The endogenous cannabinoid receptor agonist anandamide impairs memory in rats”, Behav. Pharmacol. 7, 276–284.
Mao, J., Price, D.D., Phillips, L.L., Lu, J. and Mayer, D.J. (1995) “Increases in protein kinase C immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine”, Brain Res. 677, 257–267.
Marcus, P. and Snyder, R. (1995) “Reduction of comorbid substance abuse with clozapine”, Am. J. Psychiatry 152, 959.
Markou, A. and Kenny, P.J. (2002) “Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories”, Neurotoxicity Res. 4, 297–313.
Masterson, E. and O'Shea, B. (1984) “Smoking and malignancy in schizophrenia”, Br. J. Psychiatry 145, 429–432.
Miller, M.W. (1992), “The effects of prenatal exposure to ethanol on cell proliferation and neuronal migration”, In: Miller, M., ed, Developmental of the Central Nervous System: Effects of Alcohol and Opiates (Liss, New York), pp 47–69.
Miller, M.W. (1995) “Effect of pre- or postnatal exposure to ethanol on the total number of neurons in the principal sensory nucleus of the trigeminal nerve: cell proliferation and neuronal death”, Alcohol. Clin. Exp. Res. 19, 1359–1363.
Miñana, R., Climent, E., Barettino, D., Segui, J.M., Renau-Piqueras, J. and Guerri, C. (2000) “Alcohol exposure alters the expression pattern of neural cell adhesion molecules during brain development”, J. Neurochem. 75, 954–964.
Mokler, D.A., Robinson, S.E., Johnson, J.H., Hong, J.S. and Rosecrans, J.A. (1987) “Neonatal administration of Δ9-tetrahydrocannabinol alters the neurochemical response to stress in the adult Fischer-344 rat”, Neurotoxicol. Teratol. 9, 321–326.
Molina-Holgado, F., Amaro, A., Gonzalez, M.I., Alvarez, F.J. and Leret, M.L. (1996) “Effect of maternal delta 9-tetrahydrocannabinol on developing serotonergic system”, Eur. J. Pharmacol. 316, 39–42.
Molina-Holgado, F., Alvarez, F.J., González, I., Antonio, M.T. and Leret, M.L. (1997) “Maternal exposure to Δ9-tetrahydrocannabinol (Δ9-THC) alters indolamine levels and turnover in adult male and female rat brain regions”, Brain Res. Bull. 43, 173–178.
Montoliu, C., Sancho-Tello, M., Azorin, I., Burgal, M., Valles, S., Renau-Piqueras, J. and Guerri, C. (1995) “Ethanol increases cytochrome, P4502E1 and induces oxidative stress in astrocytes”, J. Neurochem. 65, 2561–2570.
Monyer, H., Burnashev, N., Laurie, D.J., Sakmann, B. and Seeburg, P.H. (1994) “Developmental and regional expression in the rat brain and functional properties of four NMDA receptors”, Neurom 12, 529–540.
Morinan, A. (1987) “Reduction in striatal 5-hydroxytryptamine turnover following chronic administration of ethanol to rats”, Alcohol Alcohol. 22, 53–60.
Myers, R.D. and Veale, W.L. (1968) “Alcohol preference in the rat: reduction following depletion of brain serotonin”, Science 160, 1469–1471.
Naranjo, C.A., Chu, A. and Tremblay, Y. (2002) “Neurodevelopmental liabilities in alcohol dependence: central serotonin and dopamine dysfunctions”, Neurotoxicity Res. 4, 343–361.
Navarro, M., Rodríguez, F., Hernández, M.L., Ramos, J.A. and Fernández, J.J. (1994) “Motor behavior and nigrostrital dopaminergic activity in adult rats perinatally exposed to cannabinoids”, Pharmacol. Biochem. Behav. 47, 47–58.
Nunes, E.V., McGrath, P.J., Quitkin, F.M., Ocepek-Welikson, K., Stewart, J.W., Koenig, T., Wager, S. and Klein, D.F. (1995) “Imipramine treatment of cocaine abuse: possible boundaries of efficacy”, Drug Alcohol. Depend. 39, 185–195.
Olincy, A., Young, D.A. and Freedman, R. (1997) “Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers”, Biol. Psychiatry 42, 1–5.
Olive, M.F., Mehmert, K.K., Messing, R.O. and Hodge, C.W. (2000) “Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCepsilon-deficient mice”, Eur. J. Neurosci. 12, 4131–4140.
Olney, J.W., Labruyere, J., Wang, G., Wozniak, D.F., Price, M.T. and Sesma, M.A. (1991) “NMDA antagonist neurotoxicity: mechanism and prevention”, Science 254, 1515–1518.
Olney, J.W., Wozniak, D.F., Jevtovic-Todorovic, V., Farber, N.B. and Ikonomidou, C. (2002) “Glutamate and GABA receptor dysfunction in the fetal alcohol syndrome”, Neurotoxicity Res. 4, 315–325.
Pagel, M.D., Smilkstein, G., Regen, H. and Montano, D. (1990) “Psychosocial influences on new born outcomes: a controlled prospective study”, Soc. Sci. Med. 30, 597–604.
Parsons, L.H., Koob, G.F. and Weiss, F. (1995) “Serotonin dysfunction in the nucleus accumbens of rats during with-drawal after unlimited access to intravenous cocaine”, J. Pharmacol. Exp. Ther. 274, 1182–1191.
Perez-Rosado, A., Gomez, M., Manzanares, J., Ramos, J.A. and Fernandez-Ruiz, J. (2002) “Changes in prodynorphin and POMC gene expression in several brain regions of rat fetuses prenatally exposed to Δ9-tetrahydrocannabinol”, Neurotoxicity Res. 4, 211–218.
Persico, A.M., Mengual, E., Moessner, R., Hall, F.S., Revay, R.S., Sora, I., Arellano, J., DeFelipe, J., Gimene-Amaya, J.M., Conciatori, M., Marino, R., Baldi, A., Cabib, S., Pascucci T., Uhl, G.R., Murphy, D.L., Lesch, K.P., Keller, F. and Hall, S.F. (2001) “Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine releae”, J. Neurosci. 21, 6862–6873.
Peterson, D.J., Trujillo, K.A. (2001) The, NMDA receptor antagonist memantine inhibits morphine-induced behavioral and neural plasticity. Presented by Trujillo's team at College on Problems of Drug Dependence Annual Meeting, Scottsdale, AZ.
Piazza, P.V., Rouge-Pont, E., Deminiere, J.M., Kharoubi, M., Le Moal, M. and Simon, H. (1991) “Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop, amphetamine self-administration”, Brain Res. 567, 169–174.
Poulter, M.O., Barker, J.L., O'Carroll, A.M., Lolait, S.J. and Mahan, L.C. (1993) “Co-existent expression of GABAA receptor beta 2, beta 3 and gamma 2 subunit messenger RNAs during embryogenesis and early postnatal development of the rat central nervous system”, Neuroscience 53, 1019–1033.
Ramanathan, R., Wilkemeyer, M.F., Mittal, B., Perides, G. and Charness, M.E. (1996) “Alcohol inhibits cell-cell adhesion mediated by human L1”, J. Cell Biol. 133, 381–390.
Ramos, J.A., de Miguel, R., Cebeira, M., Hernandez, M. and Fernandez-Ruiz, J. (2002) “Exposure to cannabinoids in the development of endogenous cannabinoid system”, Neurotoxicity Res. 4, 363–372.
Rausch, J.L., Monteiro, M.G. and Schuckit, M.A. (1991) “Platelet serotonin uptake in men with family histories of alcoholism”, Neuropsychopharmacology 4, 83–86.
Regan, R.F. and Guo, Y. (1997) “Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures”, Brain Res. 764, 133–140.
Rifas, L., Towler, D.A. and Avioli, L.V. (1997) “Gestational exposure to ethanol suppresses msx2 expression in developing mouse embryos”, Proc. Natl. Acad. Sci. USA 94, 7549–7554.
Robinson, D., Mayerhoff, D., Alvir, J., Cooper, T. and Lieberman, J. (1991) “Mood responses of remitted schizophrenics to methylphenidate infusion”, Psychopharmacology 105, 247–252.
Rodríguez de Fonseca, F., Cebeira, M., Fernández-Ruiz, J.J., Navarro, M. and Ramos, J.A. (1991) “Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons”, Neuroscience 43, 713–723.
Rosenthal, N.E., Davenport, Y., Cowdry, R.W., Webster, M.H. and Goodwin, F.K. (1980) “Monoamine metabolites in cerebrospinal fluid of depressive subgroups”, Psychiatry, Res. 2, 113–119.
Ross, S.A., McCaffery, P.J., Drager, U.C. and De Luca, L.M. (2000) “Retinoids, in embryonal development”, Physiol. Rev. 80, 1021–1054.
Sari, Y., Powrozek, T. and Zhou, F.C. (2001) “Alcohol deters the outgrowth of serotonergic neurons at midgestation”, J. Biomed. Sci. 8, 119–125.
Schneier, F.R. and Siris, S.G. (1987) “A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice”, J. Nerv. Ment. Dis. 175, 641–652.
Schuckit, M.A., Gold, E. and Risch, C. (1987a) “Plasma cortisol levels following ethanol in sons of alcoholics and controls”, Arch. Gen. Psychiatry 44, 942–945.
Schuckit, M.A., Gold, E. and Risch, C. (1987b) “Serum prolactin levels in sons of alcoholics and control subjects”, Am. J. Psychiatry 144, 854–859.
Shivachar, A.C., Martin, B.R. and Ellis, E.F. (1996) “Anandamide and Δ9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A”, Biochem. Pharmacol. 51, 669–676.
Simpkins, J.W., Rajakumar, G., Zhang, Y.Q., Simpkins, C.E., Greenwald, D., Yu, C.J., Bodor, N. and Day, A.L. (1997) “Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat”, J. Neurosurg. 87, 724–730.
Singer, C.A., Rogers, K.L., Strickland, T.M. and Dorsa, D.M. (1996) “Estrogen protects primary cortical neurons from glutamate toxicity”, Neurosci. Lett. 212, 13–16.
Singer, C.A., Rogers, K.L. and Dorsa, D.M. (1998) “Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons”, NeuroReport 9, 2565–2568.
Sjötrom, K., Valentin, L., Thelin, T. and Marsal, K. (1997) “Maternal anxiety in late pregnancy and fetal hemodynamics”, Eur. J. Obstet. Gynecol. Reprod. Biol. 74, 149–155.
Stone, D.J., Rozovsky, I., Morgan, T.E., Anderson, C.P., Hajain, H. and Finch, C.E. (1997) “Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro”, Exp. Neurol. 143, 313–318.
Thanos, P.K., Volkow, N.D., Freimuth, P., Umegaki, H., Ikari, H., Roth, G., Ingram, D.K. and Hitzemann, R. (2001) “Over-expression of dopamine D2 receptors reduces alcohol self administration”, J. Neurochem. 78, 1094–1103.
Trujillo, K.A. (2002) “The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity”, Neurotoxicity Res. 4, 373–391.
Trujillo, K.A. and Akil, H. (1990) “Behavioral interactions between morphine and MK-801: analgesia, tolerance, dependence and lethality”, Soc. Neurosci. Abstr. 16, 211.
Trujillo, K.A. and Akil, H. (1991) “Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801”, Science 251, 85–87.
Trujillo, K.A., Warmoth, K.P., Peterson, D.J., Albertson, D.N., Watorski, K. and Swadley-Lewellen, R.M. (2001) “NMDA receptor antagonists inhibit the development of tolerance and sensitisation to the locomotor effects of opiates”, Soc. Neurosci. Abstr., 27.
Vallés, S., Lindo, L., Montoliu, C., Renau-Piqueras, J. and Guerri, C. (1994) “Prenatal exposure to ethanol induces changes in the nerve growth factor and its receptor in proliferating astrocytes in primary culture”, Brain Res. 656, 281–286.
Vallés, S., Felipo, V., Montoliu, C. and Guerri, C. (1995) “Alcohol exposure during brain development reduces. 3H-MK-801 binding and enhances metabotropic-glutamate receptor-stimulated phosphoinositide hydrolysis in rat hippocampus”, Life Sci. 56, 1373–1383.
Vallés S., Sancho-Tello, M., Miñana, R., Climent, E., Renau-Piqueras, J. and Guerri, C. (1996) “Glial fibrillary acidic protein expression in rat brain and in radial glia culture is delayed by prenatal ethanol exposure”, J. Neurochem. 67, 2425–2433.
Vela, G., Fuentes, J.A., Bonnin, A., Fernández-Ruiz, J.J. and Ruiz-Gayo, M. (1995) “Perinatal exposure to Δ9-tetrahydrocannabinol (Δ9-THC). leads to changes in opioid-related behavioral patterns in rats”, Brain Res. 680, 142–147.
Vela, G., Martín, S., García-Gil, L., Crespo, J.A., Ruiz-Gayo, M., Fernández-Ruiz, J.J., García-Lecumberri, C., Pelaprat, D., Fuentes, J.A., Ramos, J.A. and Ambrosio, E. (1998) “Maternal exposure to Δ9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes μ-opioid receptor binding in adult offspring female rats”, Brain Res. 807, 101–109.
Virkkunen, M., Kallio, E., Rawlings, R., Tokola, R., Poland, R.E., Guidotti, A., Nemeroff, C., Bissette, G., Kalogeras, K., Karonen, S.L. and Linnoila, M. (1994) “Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healthy volunteers”, Arch. Gen. Psychiatry 51, 28–33.
Waddington, W.W., Brown, B.S., Haertzen, C.A., Cone, E.J., Dax, E.M., Herning, R.I. and Michaelson, B.S. (1990) “Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts: a controlled, residential study”, Arch. Gen. Psychiatry 47, 861–868.
Wang, J.Y., Shum, A.Y., Lin, T.C. and Wang, Y. (1996) “Central serotonergic lesions increase, voluntary alcohol consumption in Sprague Dawley rats: moderation by long-term ethanol administration”, Alcohol. Clin. Exp. Res. 20, 1252–1259.
Webster, W.S., Walsh., D.A., McEwen., S.E. and Lipson, A.H. (1983) “Some teratogenic properties of ethanol and acetaldehyde in C57BL/6J mice: Implications for the study of the fetal alcohol syndrome”, Teratology 27, 231–243.
Weiss, F., Markou, A., Lorang, M.T. and Koob, G.F. (1992) “Basal dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration”, Brain Res. 593, 314–318.
West, R. and Gossop, M. (1994) “Overview: a comparison of withdrawal symptoms from different drug classes”, Addiction 89, 1483–1489.
West, R.J., Jarvis, M.J., Russell, M.A.H., Carruthers, M.E. and Feyerabend, C. (1984) “Effect of nicotine replacement on the cigarette withdrawal syndrome”, Br. J. Addict. 79, 215–219.
Whitaker-Azmitia, P.M., Druse, M., Walker, P. and Lauder, J.M. (1996) “Serotonin as a developmental signal”, Behav. Brain Res. 73, 19–29.
Wolf, M.E. and Jeziorski, M. (1993) “Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization”, Brain Res. 613, 291–294.
Zafar, H., Shelat, S.G., Redei, E. and Tejani-Butt, S. (2000) “Fetal alcohol exposure alters serotonin transporter sites in rat brain”, Brain Res. 856, 184–192.
Zaulyanov, L.L., Green, P.S. and Simpkins, J.W. (1999) “Glutamate receptor requirement for neuronal cell death from anoxiareoxygenation: an in vitro model for assessment of the neuroprotective effects of estrogens”, Cell. Mol. Neurobiol. 19, 705–718.
Zhou, F.C., Bledsoe, S., Lumeng, L. and Li, T.K. (1991) “Immunostained serotonergic fibers are decreased in selected brain regions of alcohol-preferring rats”, Alcohol 8, 425–431.
Zhou, F.C., Sari, Y., Zhang, J.K., Goodlett, C.R. and Li, T.-K. (2001) “Prenatal alcohol exposure retards the migration and development of serotonin neurons in fetal C57BL mice”, Brain Res. Dev. Brain. Res. 126, 147–155.
Zhou, F.C., Sari, Y., Li, T.-K., Goodlett, C. and Azmitia, E.C. (2002) “Deviations in brain early serotonergic deelopment as a result of fetal alcohol exposure”, Neurotoxicity Res. 4, 337–342.
Zhu, H. and Ho, I.K. (1998) “NMDA-R1 antisense oligonucleotide attenuates withdrawal signs from morphine”, Eur. J. Pharmacol. 352, 151–156.
Ziedonis, D.M. and Kosten, T.R. (1991) “Depression as a prognostic factor for pharmacological treatment of cocaine dependence”, Psychopharmacol. Bull. 27, 337–343.
Zimmet, S.V., Strous, R.D., Burgess, E.S., Kohnstamm, S. and Green, A.I. (2000) “Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey”, J. Clin. Pharmacol. 20, 94–98.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Palomo, T., Archer, T., Beninger, R.J. et al. Neurodevelopmental liabilities of substance abuse. neurotox res 4, 267–279 (2002). https://doi.org/10.1080/1029842021000010857
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/1029842021000010857